A drug to treat a life-threatening form of leukemia has gained federal approval.
Tasigna, known generically as nilotinib, won approval to treat chronic and accelerated phase Philadelphia chromosome-positive, chronic myeloid leukemia, a form of the blood cancer. FDA approval is specifically for use in patients who are resistant or intolerant to previous treatment, including with another drug called Gleevec also made by the Swiss pharmaceutical company Novartis AG.
The majority of experts in the field of armaments admit that made-in-Russia weapons can be referred to as best weapons in the world. To substantiate this point, suffice it to recall that many countries make their own ripoffs of world-famous Russian weapons.